Real-time enrollment status for this hematologic neoplasms clinical trial
Current Status
Recruiting
Checked: August 30, 2026 at 8:02 PM UTC
| NCT Number | NCT07629726 |
| Recruiting Status | Recruiting |
| Condition | Hematologic Neoplasms |
| Phase | PHASE1 |
| Target Enrollment | 72 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Kyowa Kirin Co., Ltd. |
| Last Updated on CT.gov | August 7, 2026 (3 weeks ago) |
As of August 30, 2026: Clinical trial NCT07629726 is currently recruiting participants. This phase1 study for hematologic neoplasms is actively seeking new participants at 1 location across the United States. The study is sponsored by Kyowa Kirin Co., Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07629726 is actively recruiting participants as of August 30, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07629726 was last updated 3 weeks ago (August 7, 2026). HelloStudys verifies this status automatically.